Yolcu ES - Search Results

1

Localized immune tolerance from FasL-functionalized PLG scaffolds.

Skoumal M, Woodward KB, Zhao H, Wang F, Yolcu ES, Pearson RM, Hughes KR, García AJ, Shea LD, Shirwan H. Skoumal M, et al. Among authors: yolcu es. Biomaterials. 2019 Feb;192:271-281. doi: 10.1016/j.biomaterials.2018.11.015. Epub 2018 Nov 13. Biomaterials. 2019. PMID: 30458362 Free PMC article.

2

Intrathymic immune regulation with donor class I allopeptides leads to the development of immunoregulatory cells that maintain tolerance to cardiac allografts.

Shirwan H, Mhoyan A, Yolcu E, Ibrahim S. Shirwan H, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):80. doi: 10.1016/s0041-1345(00)01912-6. Transplant Proc. 2001. PMID: 11266712 No abstract available.

3

Autoimmune responses regulate alloimmunity for prolonged cardiac allograft survival.

Yolcu E, Fang J, Shirwan H. Yolcu E, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):93. doi: 10.1016/s0041-1345(00)01920-5. Transplant Proc. 2001. PMID: 11266721 No abstract available.

4

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.

Yolcu ES, Askenasy N, Singh NP, Cherradi SE, Shirwan H. Yolcu ES, et al. Immunity. 2002 Dec;17(6):795-808. doi: 10.1016/s1074-7613(02)00482-x. Immunity. 2002. PMID: 12479825 Free article.

5

Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.

Askenasy N, Yolcu ES, Shirwan H, Wang Z, Farkas DL. Askenasy N, et al. Among authors: yolcu es. Stem Cells. 2003;21(2):200-7. doi: 10.1634/stemcells.21-2-200. Stem Cells. 2003. PMID: 12634416

6

Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection.

Askenasy N, Yolcu ES, Wang Z, Shirwan H. Askenasy N, et al. Among authors: yolcu es. Circulation. 2003 Mar 25;107(11):1525-31. doi: 10.1161/01.cir.0000064893.96179.7e. Circulation. 2003. PMID: 12654611

7

Predominant expression of the Th2 response in chronic cardiac allograft rejection.

Mhoyan A, Wu GD, Kakoulidis TP, Que X, Yolcu ES, Cramer DV, Shirwan H. Mhoyan A, et al. Among authors: yolcu es. Transpl Int. 2003 Aug;16(8):464-73. doi: 10.1007/s00147-003-0590-6. Epub 2003 Apr 24. Transpl Int. 2003. PMID: 12712237

8

Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides.

Shirwan H, Mhoyan A, Kakoulidis TP, Yolcu ES, Ibrahim S. Shirwan H, et al. Among authors: yolcu es. Am J Transplant. 2003 May;3(5):581-9. doi: 10.1034/j.1600-6143.2003.00052.x. Am J Transplant. 2003. PMID: 12752314 Free article.

9

Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells.

Shirwan H, Mhoyan A, Yolcu ES, Que X, Ibrahim S. Shirwan H, et al. Among authors: yolcu es. Transpl Immunol. 2003 Apr-Jun;11(2):179-85. doi: 10.1016/S0966-3274(03)00004-2. Transpl Immunol. 2003. PMID: 12799202

10

A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.

Singh NP, Yolcu ES, Taylor DD, Gercel-Taylor C, Metzinger DS, Dreisbach SK, Shirwan H. Singh NP, et al. Among authors: yolcu es. Cancer Res. 2003 Jul 15;63(14):4067-73. Cancer Res. 2003. PMID: 12874008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters